The hemoglobin glycation index (HGI) effectively captures individual variations in glycation, its association with cognitive impairment remains unclear.
Objective
The purpose of this study was to investigate the relationship between HGI and cognitive impairment risk in the Chinese population.
Methods
Data from the China Health and Retirement Longitudinal Study (CHARLS) between 2011 and 2015 were analyzed. Cognitive function was assessed using the American Health and Retirement Study's methodology, which included episodic memory and mental status. Multivariate Cox proportional hazards models and restricted cubic splines were used to examine the link between HGI and the likelihood of cognitive impairment, specific cognitive domains included. Moreover, the potential inflection points were investigated using saturation threshold effect analysis, with bootstrap resampling applied for internal validation.
Results
A U-shaped relationship was observed between HGI and the risk of cognitive impairment, as demonstrated by the restricted cubic spline analysis (p for non-linearity <0.001). The primary analysis identified an inflection point at approximately 0.085. Internal validation via bootstrapping yielded a 95% empirical confidence interval of 0.013 to 0.255 for this point. Conversely, HGI levels above 0.085 resulted in a 70.6% increase in the hazard ratio of cognitive impairment (all p < 0.05).
Conclusions
In the Chinese population, our results point to a U-shaped association between HGI and the risk of cognitive impairment, suggesting that both very low and very high HGI levels raise the risk of cognitive impairment, especially execution and memory.
LaiJMGillTMCooneyLM, et al.Everyday decision-making ability in older persons with cognitive impairment. Am J Geriatr Psychiatry2008; 16: 693–696.
2.
NicholsESzoekeCEIVollsetSE, et al.Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol2019; 18: 88–106.
3.
LivingstonGHuntleyJSommerladA, et al.Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet2020; 396: 413–446.
4.
JiaLQuanMFuY, et al.Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol2020; 19: 81–92.
5.
MukadamNAndersonRKnappM, et al.Effective interventions for potentially modifiable risk factors for late-onset dementia: a costs and cost-effectiveness modelling study. Lancet Healthy Longev2020; 1: e13–e20.
6.
SchwartzSSHermanMETunMTH, et al.The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes. BMC Med2024; 22: 82.
7.
BiesselsGJWhitmerRA. Cognitive dysfunction in diabetes: how to implement emerging guidelines. Diabetologia2020; 63: –9.
8.
ThapaMHeoYS. Label-free electrochemical detection of glucose and glycated hemoglobin (HbA1c). Biosens Bioelectron2023; 221: 114907.
9.
YangGYeungASchoolingSL, et al.Sex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: a Mendelian randomization study. eBioMedicine2022; 84: 104259.
10.
WilsonDMXingDChengJ, et al.Persistence of individual variations in glycated hemoglobin: analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Care2011; 34: 1315–1317.
11.
SacksDBKirkmanMSLittleRR. Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use. Diabetes Care2024; 47: 1104–1110.
12.
SarnowskiCHivertMF. Impact of genetic determinants of HbA1c on type 2 diabetes risk and diagnosis. Curr Diab Rep2018; 18: 52.
13.
NathanDMHermanWHLarkinME, et al.Relationship between average glucose levels and HbA1c differs across racial groups: a substudy of the GRADE randomized trial. Diabetes Care2024; 47: 2155–2163.
14.
van SteenSCJSchrieksICHoekstraJBL, et al.The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial. Eur J Prev Cardiol2017; 24: 858–866.
15.
LinLWangAHeY, et al.Effects of the hemoglobin glycation index on hyperglycemia diagnosis: results from the REACTION study. Diabetes Res Clin Pract2021; 180: 109039.
16.
MiJSongJZhaoY, et al.Association of hemoglobin glycation index and its interaction with obesity/family history of hypertension on hypertension risk: a community-based cross-sectional survey. BMC Cardiovasc Disord2020; 20: 77.
17.
MariniMAFiorentinoTVSuccurroE, et al.Association between hemoglobin glycation index with insulin resistance and carotid atherosclerosis in non-diabetic individuals. PLoS One2017; 12: e0175547.
18.
DongHWangJHuP, et al.Associations of apolipoproteinA1, high density lipoprotein cholesterol with hemoglobin glycation index and triglyceride-glucose index in Chinese adults with coronary artery disease. J Diabetes Complications2023; 37: 108516.
19.
WeiXChenXZhangZ, et al.Risk analysis of the association between different hemoglobin glycation index and poor prognosis in critical patients with coronary heart disease-A study based on the MIMIC-IV database. Cardiovasc Diabetol2024; 23: 13.
20.
FiorentinoTVMariniMASuccurroE, et al.Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. Diabetes Res Clin Pract2017; 134: 53–61.
21.
van SteenSCWoodwardMChalmersJ, et al.Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia2018; 61: 780–789.
22.
HempeJMHsiaDS. Variation in the hemoglobin glycation index. J Diabetes Complications2022; 36: 108223.
23.
CrimminsEMKimJKLangaKM, et al.Assessment of cognition using surveys and neuropsychological assessment: the Health and Retirement Study and the Aging, Demographics, and Memory Study. J Gerontol B Psychol Sci Soc Sci2011; 66B: i162–i171.
24.
LiuHZouLZhouR, et al.Long-term increase in cholesterol is associated with better cognitive function: evidence from a longitudinal study. Front Aging Neurosci2021; 13: 691423.
25.
ZhouSSongSJinY, et al.Prospective association between social engagement and cognitive impairment among middle-aged and older adults: evidence from the China Health and Retirement Longitudinal Study. BMJ Open2020; 10: e040936.
26.
DongFWWangDHChangYJ, et al.Correlation between physical activity levels and the risk of cognitive impairment in Chinese older adults. Front Aging Neurosci2025; 17: 1519494.
27.
HanXPanCCaiZ, et al.The association between sensory function changes, metabolic and inflammatory biomarkers, and cognitive impairment: two prospective cohort studies. J Gerontol A Biol Sci Med Sci2025; 80: glaf160.
28.
ZhaoQChenFSongX, et al.Hearing loss and cognitive impairment among older adults: findings from the China health and retirement longitudinal study. BMC Public Health2025; 25: 1588.
29.
QinFLuoMXiongY, et al.Prevalence and associated factors of cognitive impairment among the elderly population: a nationwide cross-sectional study in China. Front Public Health2022; 10: 1032666.
30.
TiwariAMyeongJHashemiaghdamA, et al.Mitochondrial pyruvate transport regulates presynaptic metabolism and neurotransmission. Sci Adv2024; 10: eadp7423.
31.
NikpendarMJavanbakhtMMoosavianH, et al.Effect of recurrent severe insulin-induced hypoglycemia on the cognitive function and brain oxidative status in the rats. Diabetol Metab Syndr2024; 16: 61.
32.
TanZSBeiserASFoxCS, et al.Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care2011; 34: 1766–1770.
33.
HsiaDSRasouliNPittasAG, et al.Implications of the hemoglobin glycation index on the diagnosis of prediabetes and diabetes. J Clin Endocrinol Metab2020; 105: e130–e138.
34.
MalkaRNathanDMHigginsJM. Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring. Sci Transl Med2016; 8: 359ra130.
35.
KheraPKJoinerCHCarruthersA, et al.Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes2008; 57: 2445–2452.
36.
BrownSMSmithDMAltN, et al.Tissue-specific variation in glycation of proteins in diabetes: evidence for a functional role of amadoriase enzymes. Ann N Y Acad Sci2005; 1043: 817–823.
37.
WuJDLiangDLXieY, et al.Association between hemoglobin glycation index and risk of cardiovascular disease and all cause mortality in type 2 diabetic patients: a meta-analysis. Front Cardiovasc Med2021; 8: 690689.
38.
YangSWangGMaZF, et al.Dietary advanced glycation end products-induced cognitive impairment in aged ICR mice: protective role of quercetin. Mol Nutr Food Res2020; 64: e1901019.
39.
OrtizAAMurtishawASBeckholtM, et al.Impact of chronic hyperglycemia and high-fat diet on Alzheimer’s disease-related pathology in CX3CR1 knockout mice. Metab Brain Dis2025; 40: 97.
40.
HempeJMYangSLiuS, et al.Standardizing the haemoglobin glycation index. Endocrinol Diabetes Metab2021; 4: e00299.
41.
WangYLiuHHuX, et al.Association between hemoglobin glycation index and 5-year major adverse cardiovascular events: the REACTION cohort study. Chin Med J (Engl)2023; 136: 2468–2475.
42.
PanYJingJWangY, et al.Association of hemoglobin glycation index with outcomes of acute ischemic stroke in type 2 diabetic patients. Neurol Res2018; 40: 573–580.
AlGhatrifMLakattaEGMorrellCH, et al.Dilated hypertrophic phenotype of the carotid artery is associated with accelerated age-associated central arterial stiffening. GeroScience2023; 45: 1001–1013.
45.
ScuteriABenetosASierraC, et al.Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how—a decision-making support from the working group on ‘hypertension and the brain’ of the European Society of Hypertension and from the European Geriatric Medicine Society. J Hypertens2021; 39: 90–100.
46.
ScuteriAModestinoAFrattariA, et al.Occurrence of hypotension in older participants, which 24-h ABPM parameter better correlate with?J Gerontol A Biol Sci Med Sci2012; 67: 804–810.
47.
ScuteriAMorrellCHOrru’M, et al.Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study. Int J Cardiol2016; 217: 92–98.
48.
Gómez-MartínezCBabioNJúlvezJ, et al.Glycemic dysregulations are associated with worsening cognitive function in older participants at high risk of cardiovascular disease: two-year follow-up in the PREDIMED-Plus Study. Front Endocrinol2021; 12: 754347.
49.
UngvariZTothPTarantiniS, et al.Hypertension-induced cognitive impairment: from pathophysiology to public health. Nat Rev Nephrol2021; 17: 639–654.
50.
YangJShangguanQXieG, et al.Sex-specific associations between haemoglobin glycation index and the risk of cardiovascular and all-cause mortality in individuals with pre-diabetes and diabetes: a large prospective cohort study. Diabetes Obes Metab2024; 26: 2275–2283.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
